US 11654142
Methods for the administration of certain VMAT2 inhibitors
granted A61KA61K31/4745A61K31/7048
Quick answer
US patent 11654142 (Methods for the administration of certain VMAT2 inhibitors) held by Neurocrine Biosciences, Inc. expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/4745, A61K31/7048, A61K9/0053, A61K9/20